US Stock MarketDetailed Quotes

GRTX Galera Therapeutics

Watchlist
  • 0.038
  • 0.0000.00%
15min DelayTrading Dec 2 16:00 ET
2.07MMarket Cap-74P/E (TTM)

Galera Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-74.96%4.21M
-67.03%4.58M
-8.35%46.95M
-60.74%5.18M
-14.44%11.09M
40.89%16.81M
5.53%13.88M
-30.18%51.23M
-9.06%13.19M
-36.17%12.96M
Selling and administrative expenses
-69.94%2.78M
-53.26%3.09M
12.97%22.84M
-60.43%1.99M
2.91%4.99M
74.68%9.25M
30.95%6.61M
-3.52%20.21M
-4.98%5.02M
-11.55%4.85M
-General and administrative expense
-69.94%2.78M
-53.26%3.09M
12.97%22.84M
-60.43%1.99M
2.91%4.99M
74.68%9.25M
30.95%6.61M
-3.52%20.21M
-4.98%5.02M
-11.55%4.85M
Research and development costs
-81.09%1.43M
-79.54%1.49M
-22.24%24.12M
-60.94%3.19M
-24.82%6.09M
13.94%7.56M
-10.30%7.27M
-40.84%31.01M
-11.40%8.16M
-45.28%8.11M
Operating profit
74.96%-4.21M
67.03%-4.58M
8.35%-46.95M
60.74%-5.18M
14.44%-11.09M
-40.89%-16.81M
-5.53%-13.88M
30.18%-51.23M
9.06%-13.19M
36.17%-12.96M
Net non-operating interest income expense
103.82%149K
105.12%196K
11.26%-9.82M
86.66%-410K
45.48%-1.68M
-48.59%-3.91M
-67.23%-3.83M
-54.50%-11.07M
-33.19%-3.07M
-32.27%-3.07M
Non-operating interest income
-69.84%149K
-50.38%196K
215.22%1.6M
18.00%295K
140.35%411K
595.77%494K
2,721.43%395K
1,481.25%506K
6,150.00%250K
5,600.00%171K
Non-operating interest expense
--0
--0
-1.36%11.41M
-78.79%705K
-35.69%2.09M
62.99%4.4M
83.37%4.22M
60.84%11.57M
43.77%3.32M
39.45%3.25M
Other net income (expense)
-4K
-231,100.00%-2.31M
-200.00%-1K
-230,900.00%-2.31M
-1K
75.00%-1K
200.00%1K
50.00%-1K
Gain on sale of security
---4K
----
-200.00%-3K
-200.00%-1K
0.00%-1K
----
---1K
75.00%-1K
200.00%1K
50.00%-1K
Special income (charges)
----
----
---2.31M
--0
---2.31M
----
----
--0
--0
--0
-Less：Restructuring and merger&acquisition
----
----
--2.31M
--0
--2.31M
----
----
--0
--0
--0
Income before tax
80.38%-4.06M
75.26%-4.38M
5.15%-59.08M
65.64%-5.59M
5.99%-15.07M
-42.27%-20.71M
-14.68%-17.71M
22.65%-62.29M
3.27%-16.26M
29.14%-16.03M
Income tax
0
-70K
Net income
80.38%-4.06M
75.26%-4.38M
5.05%-59.08M
65.49%-5.59M
5.99%-15.07M
-42.27%-20.71M
-14.68%-17.71M
22.74%-62.22M
3.68%-16.19M
29.14%-16.03M
Net income continuous Operations
80.38%-4.06M
75.26%-4.38M
5.05%-59.08M
65.49%-5.59M
5.99%-15.07M
-42.27%-20.71M
-14.68%-17.71M
22.74%-62.22M
3.68%-16.19M
29.14%-16.03M
Minority interest income
Net income attributable to the parent company
80.38%-4.06M
75.26%-4.38M
5.05%-59.08M
65.49%-5.59M
5.99%-15.07M
-42.27%-20.71M
-14.68%-17.71M
22.74%-62.22M
3.68%-16.19M
29.14%-16.03M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
80.38%-4.06M
75.26%-4.38M
5.05%-59.08M
65.49%-5.59M
5.99%-15.07M
-42.27%-20.71M
-14.68%-17.71M
22.74%-62.22M
3.68%-16.19M
29.14%-16.03M
Basic earnings per share
85.42%-0.07
84.00%-0.08
42.17%-1.33
94.83%-0.03
45.00%-0.33
11.11%-0.48
13.79%-0.5
26.28%-2.3
9.38%-0.58
30.23%-0.6
Diluted earnings per share
85.42%-0.07
84.00%-0.08
42.17%-1.33
94.83%-0.03
45.00%-0.33
11.11%-0.48
13.79%-0.5
26.28%-2.3
9.38%-0.58
30.23%-0.6
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -74.96%4.21M-67.03%4.58M-8.35%46.95M-60.74%5.18M-14.44%11.09M40.89%16.81M5.53%13.88M-30.18%51.23M-9.06%13.19M-36.17%12.96M
Selling and administrative expenses -69.94%2.78M-53.26%3.09M12.97%22.84M-60.43%1.99M2.91%4.99M74.68%9.25M30.95%6.61M-3.52%20.21M-4.98%5.02M-11.55%4.85M
-General and administrative expense -69.94%2.78M-53.26%3.09M12.97%22.84M-60.43%1.99M2.91%4.99M74.68%9.25M30.95%6.61M-3.52%20.21M-4.98%5.02M-11.55%4.85M
Research and development costs -81.09%1.43M-79.54%1.49M-22.24%24.12M-60.94%3.19M-24.82%6.09M13.94%7.56M-10.30%7.27M-40.84%31.01M-11.40%8.16M-45.28%8.11M
Operating profit 74.96%-4.21M67.03%-4.58M8.35%-46.95M60.74%-5.18M14.44%-11.09M-40.89%-16.81M-5.53%-13.88M30.18%-51.23M9.06%-13.19M36.17%-12.96M
Net non-operating interest income expense 103.82%149K105.12%196K11.26%-9.82M86.66%-410K45.48%-1.68M-48.59%-3.91M-67.23%-3.83M-54.50%-11.07M-33.19%-3.07M-32.27%-3.07M
Non-operating interest income -69.84%149K-50.38%196K215.22%1.6M18.00%295K140.35%411K595.77%494K2,721.43%395K1,481.25%506K6,150.00%250K5,600.00%171K
Non-operating interest expense --0--0-1.36%11.41M-78.79%705K-35.69%2.09M62.99%4.4M83.37%4.22M60.84%11.57M43.77%3.32M39.45%3.25M
Other net income (expense) -4K-231,100.00%-2.31M-200.00%-1K-230,900.00%-2.31M-1K75.00%-1K200.00%1K50.00%-1K
Gain on sale of security ---4K-----200.00%-3K-200.00%-1K0.00%-1K-------1K75.00%-1K200.00%1K50.00%-1K
Special income (charges) -----------2.31M--0---2.31M----------0--0--0
-Less：Restructuring and merger&acquisition ----------2.31M--0--2.31M----------0--0--0
Income before tax 80.38%-4.06M75.26%-4.38M5.15%-59.08M65.64%-5.59M5.99%-15.07M-42.27%-20.71M-14.68%-17.71M22.65%-62.29M3.27%-16.26M29.14%-16.03M
Income tax 0-70K
Net income 80.38%-4.06M75.26%-4.38M5.05%-59.08M65.49%-5.59M5.99%-15.07M-42.27%-20.71M-14.68%-17.71M22.74%-62.22M3.68%-16.19M29.14%-16.03M
Net income continuous Operations 80.38%-4.06M75.26%-4.38M5.05%-59.08M65.49%-5.59M5.99%-15.07M-42.27%-20.71M-14.68%-17.71M22.74%-62.22M3.68%-16.19M29.14%-16.03M
Minority interest income
Net income attributable to the parent company 80.38%-4.06M75.26%-4.38M5.05%-59.08M65.49%-5.59M5.99%-15.07M-42.27%-20.71M-14.68%-17.71M22.74%-62.22M3.68%-16.19M29.14%-16.03M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 80.38%-4.06M75.26%-4.38M5.05%-59.08M65.49%-5.59M5.99%-15.07M-42.27%-20.71M-14.68%-17.71M22.74%-62.22M3.68%-16.19M29.14%-16.03M
Basic earnings per share 85.42%-0.0784.00%-0.0842.17%-1.3394.83%-0.0345.00%-0.3311.11%-0.4813.79%-0.526.28%-2.39.38%-0.5830.23%-0.6
Diluted earnings per share 85.42%-0.0784.00%-0.0842.17%-1.3394.83%-0.0345.00%-0.3311.11%-0.4813.79%-0.526.28%-2.39.38%-0.5830.23%-0.6
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion with Explanatory Notes----
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Ecopetrol
EC
+1.26%
Lennar Corp
LEN
+0.80%
D.R. Horton
DHI
+0.70%
Alphabet-C
GOOG
+0.59%
Alphabet-A
GOOGL
+0.50%

Unlock the Full List